MedPath

A randomized control trial regarding the efficacy of an app series based on Eye Movement Desensitization and Reprocessing (EMDR) for Posttraumatic Stress Disorder (PTSD) symptoms.

Not Applicable
Conditions
Posttraumatic Stress Disorder
Anxiety
Insomnia
Medically unexplained pain
Mental Health - Anxiety
Registration Number
ACTRN12622000748718
Lead Sponsor
Mark D Grant
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Diagnosis of PTSD, or symptoms consistent with PTSD as measured by PCL-C and over age 18.

Exclusion Criteria

(1) Lack of access to mobile apps; (2) on-going self-harm/suidical or homidical ideation, (3) diagnosis of psychotic or bipolar disorder (4) non-English speakers; (5) diagnosis of dissociative disorder (6) organic mental disorder (7) substance abuse and (8) significant cognitive impairment (eg; severe intellectual disability, dementia).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath